Adherence to prophylactic treatment of patients with haemophilia A and B using the VERITAS-Pro in a population on the Colombian Caribbean Coast
Keywords:
Haemophilia, VERITAS-Pro, Prophylaxis, Adherence, Colombian Caribbean CoastAbstract
Background: Haemophilia is a disease that results in high costs worldwide, and whereby there is limited access to prophylactic treatment due to poor health conditions and difficultly in accessing healthcare; therefore, it becomes necessary to establish policies to improve the implementation or adherence of treatments in patients. Methods: An observational, cross-sectional, and prospective study was conducted, with the application of the VERITAS-Pro test, which was validated using Cronbach´s alpha. The adherence was determined using a scale-based on VERITAS-Pro. Previously, sociodemographic and clinical variables were collected in order to relate the data to a questionnaire. Results: 32 patients with haemophilia and prophylaxis treatment were included. They were divided into adults (>18 years-old) and minors (<18 years-old). The majority of participants evidenced haemophilia A (77.8% of adults and 64.3% of minors) and the majority of participants had severe haemophilia (77.8% of adults and 85.0% of minors). The internal consistency showed high reliability (α= 0.811 in minors and α= 0.858 in adults). The results showed that 66.7% of adults evidenced adherence while minors showed 50.0%. These results were compared with variables such as type of hemophilia, degree of hemophilia, presence of arthropathy, emergency admission, family history and inhibitors of coagulation factors. Conclusions: The VERITAS-Pro questionnaire showed high levels of consistency and reproducibility. The study population showed a high degree of adherence. It was therefore useful to evaluate the adherence of haemophiliac patients in the Colombian Caribbean.
Downloads
References
Muñoz-Grass LF, Palacios-Espinosa X. Calidad de vida y hemofilia: Una revisión de la literatura. CES Psicol. 2015;8(1):169–91.
World Federation of Hemophilia. Report on the Annual Global Survey 2020 [Internet]. Montréal, Canada; 2021. Available from: https://wfh.org/data-collection/#ags
Fondo Colombiano de Enfermedades de Alto Costo. Situación de la hemofilia en Colombia 2018. 2018. p. 1–238.
Bogotá-Pizarro D, Galeano-Pizarro CF. Determinación de costos médicos directos del tratamiento de la hemofilia tipo B sin inhibidores en Colombia. 2019.
Fuenmayor Castaño A, Jaramillo Restrepo M, Salinas Durán F. Calidad de vida en una población con hemofilia: estudio de corte transversal en un centro de tratamiento de hemofilia TT - Quality of life in a population with haemophilia: a cross-sectional study from a single haemophilia treatment centre. Rev Colomb Reumatol [Internet]. 2017;24(1):18–24. Available from: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0121-81232017000100018&lang=pt%0Ahttp://www.scielo.org.co/pdf/rcre/v24n1/0121-8123-rcre-24-01-00018.pdf
Cassis F. Atención psicosocial para personas con hemofilia. 2007. p. 1–13.
Garre Andreo RS, Garre Andreo P, Giménez Fernández M, García Serrano JM, García Ruiz BM. Adherencia al tratamiento profiláctico en pacientes hemofílicos A severos. Eur J Child Dev Educ Psychopathol. 2017;5(1):5–20.
van Os S, Troop N, Ryder N, Hart DP. Adherence to prophylaxis in adolescents and young adults with severe haemophilia A, a qualitative study with patients. Heal Psychol Behav Med. 2018;6(1):277–300.
Giordano P, Franchini M, Lassandro G, Faienza MF, Valente R, Molinari AC. Issues in pediatric haemophilia care. Ital J Pediatr. 2013;39(1):1–5.
Allen KN, Kachalsky E. Aging with hemophilia: Implications for social work practice. Soc Work Health Care. 2010;49(4):327–44.
Thornburg CD, Duncan NA. Patient Preference and Adherence Dovepress Treatment adherence in hemophilia. Patient Prefer Adherence [Internet]. 2017;11–1677. Available from: http://dx.doi.org/10.2147/PPA.S139851
Duncan NA, Kronenberger W, Roberson C, Shapiro A. VERITAS-Pro: A new measure of adherence to prophylactic regimens in haemophilia. Haemophilia. 2010;16(2):247–55.
Ferreira AA, Leite ICG, Duncan NA. Validation of the Brazilian version of the VERITAS-Pro scale to assess adherence to prophylactic regimens in hemophilia. Hematol Transfus Cell Ther. 2018;40(1):18–24.
Thornburg CD, Duncan NA. Treatment-adherence-in-hemophilia. Dovepress. 2017;1677–86.
Cuesta-Barriuso R, Torres-Ortuño A, Galindo-Piñana P, Nieto-Munuera J, Duncan N, López-Pina JA. Validation of the VERITAS-Pro treatment adherence scale in a Spanish sample population with hemophilia. Patient Prefer Adherence. 2017;11:653–60.
Jandial A, Mishra K, Sandal R, Jindal N, Goni D, Lad D, et al. Hemophilia in the developing world: Transforming lives through international collaboration. Blood Adv. 2018;2:39–41.
Alvíz-Amador A, Taron-Dunoyer A, Diaz-Caballero A. Quality of life of hemophiliac patients and satisfaction with their prophylactic treatment in Colombia. Arch Venez Farmacol y Ter. 2022;40(9):895–901.
Chang CY, Li TY, Cheng SN, Pan RY, Wang HJ, Lin SY, et al. Prevalence and severity by age and other clinical correlates of haemophilic arthropathy of the elbow, knee and ankle among Taiwanese patients with haemophilia. Haemophilia. 2017;23(2):284–91.
Rodriguez-Merchan EC. Musculoskeletal complications of hemophilia. HSS J. 2010;6(1):37–42.
McMillan C, Shapiro S, Whitehurst D, Hoyer L, Rao A, Lazerson J. The natural history of factor VIII:C inhibitors in patients with hemophilia A: a national cooperative study. II. Observations on the initial development of factor VIII:C inhibitors. Blood. 1988;71(2):344–8.
Goto M, Takedani H, Yokota K, Haga N. Strategies to encourage physical activity in patients with hemophilia to improve quality of life. J Blood Med. 2016;7:85–98.
Zhou Z, Riske B, Forsberg AD, Ullman M, Baker JR, Koerper MA, et al. Self-reported barriers to hemophilia care in people with factor VIII deficiency. Am J Prev Med [Internet]. 2011;41(6 SUPPL.4):S346–53. Available from: http://dx.doi.org/10.1016/j.amepre.2011.09.003
Honorato J. Adherencia al tratamiento farmacológico. Med Respir. 2015;8(1):47–52.
Porras-Moreno A, Ugalde-Solera D. Immunotolerance induction in a pediatric hemophilic patient in Costa Rica. Acta Med Costarric. 2018;60(3):139–41.
Coppola A. Treatment of hemophilia: a review of current advances and ongoing issues. J Blood Med. 2010;1:183–95.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 AVFT – Archivos Venezolanos de Farmacología y Terapéutica
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
